Literature DB >> 16793963

Increased adiponectin receptor-1 expression in adipose tissue of impaired glucose-tolerant obese subjects during weight loss.

M J Kim1, M Maachi, C Debard, E Loizon, K Clément, E Bruckert, B Hainque, J Capeau, H Vidal, J P Bastard.   

Abstract

OBJECTIVE: To investigate the mRNA expression of adiponectin, AdipoR1 and AdipoR2, the two recently cloned adiponectin receptors and peroxisome proliferator activated receptor (PPAR)gamma2 in adipose tissue of obese individuals before and during a very low calorie diet (VLCD) inducing weight loss.
METHODS: Twenty-three non-diabetic obese subjects with normal (NGT, n = 11) or impaired glucose tolerance (IGT, n = 12) (age, 47 +/- 3 years; body mass index, 39.3 +/- 1.3 kg/m2) were studied before and after a 3-week 3.9 MJ diet daily without exercise. mRNA levels of nine IGT and six NGT subjects were measured by real-time PCR in s.c. abdominal adipose tissue.
RESULTS: Metabolic parameters and insulin sensitivity were improved by VLCD in the IGT group, but minimally affected in the NGT group. VLCD increased expression of AdipoR1 in the IGT (P = 0.02), but not in the NGT group. Adiponectin, AdipoR2 and PPARgamma2 mRNA levels did not change during VLCD in any group. In the IGT, but not in the NGT group, AdipoR1 and AdipoR2 expressions were positively related to that of PPARgamma2 and, after VLCD, AdipoR1 and AdipoR2 expressions were positively related to each other and to that of adiponectin.
CONCLUSION: In the NGT group, the 3-week VLCD inducing weight loss did not modify metabolic parameters, insulin sensitivity and the expression of the adiponectin system in adipose tissue. By contrast, in the IGT group, AdipoR1 expression increased and we found a coordinate regulation of the expression of adiponectin and its receptors. These modifications could participate, through adiponectin action on adipocytes, to the improved metabolic parameters observed in IGT subjects.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16793963     DOI: 10.1530/eje.1.02194

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  7 in total

1.  Genistein induces pancreatic beta-cell proliferation through activation of multiple signaling pathways and prevents insulin-deficient diabetes in mice.

Authors:  Zhuo Fu; Wen Zhang; Wei Zhen; Hazel Lum; Jerry Nadler; Josep Bassaganya-Riera; Zhenquan Jia; Yanwen Wang; Hara Misra; Dongmin Liu
Journal:  Endocrinology       Date:  2010-05-19       Impact factor: 4.736

2.  Effects of Weight Loss with and without Exercise on Regional Body Fat Distribution in Postmenopausal Women.

Authors:  Monica C Serra; Jacob B Blumenthal; Odessa R Addison; Ann J Miller; Andrew P Goldberg; Alice S Ryan
Journal:  Ann Nutr Metab       Date:  2017-06-09       Impact factor: 3.374

3.  A pilot study of sampling subcutaneous adipose tissue to examine biomarkers of cancer risk.

Authors:  Kristin L Campbell; Karen W Makar; Mario Kratz; Karen E Foster-Schubert; Anne McTiernan; Cornelia M Ulrich
Journal:  Cancer Prev Res (Phila)       Date:  2009-01

4.  Guava leaf extracts alleviate fatty liver via expression of adiponectin receptors in SHRSP.Z-Leprfa/Izm rats.

Authors:  Hisae Yoshitomi; Xiangyu Guo; Tonghua Liu; Ming Gao
Journal:  Nutr Metab (Lond)       Date:  2012-02-20       Impact factor: 4.169

5.  Associations among serum pro- and anti-inflammatory cytokines, metabolic mediators, body condition, and uterine disease in postpartum dairy cows.

Authors:  Ramanathan K Kasimanickam; Vanmathy R Kasimanickam; Jesse R Olsen; Erin J Jeffress; Dale A Moore; John P Kastelic
Journal:  Reprod Biol Endocrinol       Date:  2013-11-09       Impact factor: 5.211

Review 6.  Adiponectin System (Rescue Hormone): The Missing Link between Metabolic and Cardiovascular Diseases.

Authors:  Meneerah Abdulrahman Aljafary; Ebtesam Abdullah Al-Suhaimi
Journal:  Pharmaceutics       Date:  2022-07-07       Impact factor: 6.525

7.  OBEDIS Core Variables Project: European Expert Guidelines on a Minimal Core Set of Variables to Include in Randomized, Controlled Clinical Trials of Obesity Interventions.

Authors:  Maud Alligier; Romain Barrès; Ellen E Blaak; Yves Boirie; Jildau Bouwman; Paul Brunault; Kristina Campbell; Karine Clément; I Sadaf Farooqi; Nathalie J Farpour-Lambert; Gema Frühbeck; Gijs H Goossens; Jorg Hager; Jason C G Halford; Hans Hauner; David Jacobi; Chantal Julia; Dominique Langin; Andrea Natali; Martin Neovius; Jean Michel Oppert; Uberto Pagotto; Antonio L Palmeira; Helen Roche; Mikael Rydén; André J Scheen; Chantal Simon; Thorkild I A Sorensen; Luc Tappy; Hannele Yki-Järvinen; Olivier Ziegler; Martine Laville
Journal:  Obes Facts       Date:  2020-01-16       Impact factor: 3.942

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.